The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pfizer; Roche
Expert Testimony - MSD
Travel, Accommodations, Expenses - AstraZeneca
Updated analysis of the inducible T-cell co-stimulatory receptor (ICOS) agonist, GSK3359609 (GSK609), combination with pembrolizumab (PE) in patients (pts) with anti-PD-1/L1 treatment-naïve head and neck squamous cell carcinoma (HNSCC).
 
Eric Angevin
Consulting or Advisory Role - Celgene; GlaxoSmithKline; MedImmune; Merck Sharp & Dohme; Roche
Research Funding - Abbvie; GlaxoSmithKline; MedImmune; Octimet; Pfizer; Sanofi
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Innate Pharma
 
Stefanie L. Groenland
No Relationships to Disclose
 
Annette May Ling Lim
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Juan Martin-Liberal
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pierre Fabre; Roche
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; MSD; Novartis; Pfizer; Pierre Fabre; Roche
 
Victor Moreno
Employment - START
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Janssen Oncology; Merck
Speakers' Bureau - Bayer
Research Funding - Abbvie (Inst); ACEA Biosciences (Inst); Adaptimmune (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); E-therapeutics (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Menarini (Inst); Merck (Inst); Nanobiotix (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); PsiOxus Therapeutics (Inst); Puma Biotechnology (Inst); Regeneron (Inst); RigonTEC (Inst); Roche (Inst); Sanofi (Inst); Sierra Oncology (Inst); Synthon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tesaro (Inst); Transgene (Inst)
Expert Testimony - Medscape/Bayer; Nanobiotix
Travel, Accommodations, Expenses - Sanofi/Regeneron
Other Relationship - Bristol-Myers Squibb
 
Jose Manuel Trigo
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; MSD; Takeda
Speakers' Bureau - AstraZeneca; Bayer; Eisai; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Christophe Le Tourneau
Honoraria - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck Serono; MSD; Nanobiotix; Novartis; Rakuten Medical; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; MSD; Nanobiotix; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD
 
Matthen Mathew
Stock and Other Ownership Interests - CorMedix (I); Navinta (I)
 
Daniel C. Cho
Consulting or Advisory Role - HUYA Bioscience International; Nektar; Pfizer; PureTech; Torque
Expert Testimony - Abbott/AbbVie; Genentech
 
Aaron Richard Hansen
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Merck; Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Merck; Novartis
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
David Vicente
No Relationships to Disclose
 
Michele Maio
Stock and Other Ownership Interests - Theravance
Honoraria - Alfasigma; Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pierre Fabre; Roche
Consulting or Advisory Role - Alfasigma; AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pierre Fabre; Roche
Patents, Royalties, Other Intellectual Property - DNA Hypomethylating agents for cancer therapy
Travel, Accommodations, Expenses - Alfasigma; Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pierre Fabre; Roche
 
Antoine Italiano
Honoraria - Bayer; Daiichi Sankyo; Epizyme; IPSEN; Lilly; Novartis; Roche
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Epizyme; Immune Design; Lilly; Roche
Research Funding - AstraZeneca/MedImmune; Bayer; Merck Serono; Merck Serono; MSD Oncology; PharmaMar; Roche
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
 
Jessica Ruth Bauman
Consulting or Advisory Role - AstraZeneca; Bayer; Pfizer; Pfizer
Travel, Accommodations, Expenses - Trident Pharmaceuticals
 
Michael Jon Chisamore
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Helen Zhou
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Catherine Elizabeth Ellis
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Marc S. Ballas
Employment - GlaxoSmithKline
Leadership - GlaxoSmithKline
Stock and Other Ownership Interests - Bristol-Myers Squibb; GlaxoSmithKline
Research Funding - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - AstraZeneca; GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Axel Hoos
Employment - GlaxoSmithKline; GlaxoSmithKline
Leadership - Imugene; Imugene
Stock and Other Ownership Interests - GlaxoSmithKline; GlaxoSmithKline; Imugene; Imugene
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline (Inst); GlaxoSmithKline (Inst)
Other Relationship - Board member Sabin Institute, CRI; CRI; Sabin Institute
 
Danny Rischin
Research Funding - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Merck; Regeneron
Travel, Accommodations, Expenses - Merck